Alternative splicing as a biomarker and potential target for drug discovery. | |||
---|---|---|---|
분류 | drug discovery | 조회 | 1491 |
발행년도 | 2015 | 등록일 | 2015-10-10 |
출처 | Acta Pharmacol Sin (바로가기) | ||
Alternative splicing is a key process of multi-exonic gene expression during pre-mRNA maturation. In this process, particular exons of a gene will be included within or excluded from the final matured mRNA, and the resulting transcripts generate diverse protein isoforms. Recent evidence demonstrates that approximately 95% of human genes with multiple exons undergo alternative splicing during pre-mRNA maturation.
(후략)
|
|
이전글 | Approaches of targeting Rho GTPases in cancer drug discovery. |
---|---|
다음글 | Development of nanotoxicology: implications for drug delivery and medical devices. |